Document is current
Any future updates will be listed below
-
Authors
Aguilar-Toalá, José Eleazar
Arioli, Stefania
Behare, Pradip https://orcid.org/0000-0002-0403-2398
Belzer, Clara
Berni Canani, Roberto https://orcid.org/0000-0002-5169-9574
Chatel, Jean-Marc
D’Auria, Enza https://orcid.org/0000-0003-2750-5810
de Freitas, Mônica Queiroz
Elinav, Eran https://orcid.org/0000-0002-5775-2110
Esmerino, Erick Almeida
García, Hugo S.
da Cruz, Adriano Gomes
González-Córdova, Aarón F.
Guglielmetti, Simone https://orcid.org/0000-0002-8673-8190
de Toledo Guimarães, Jonas https://orcid.org/0000-0002-0414-6678
Hernández-Mendoza, Adrián https://orcid.org/0000-0002-2360-7484
Langella, Philippe https://orcid.org/0000-0001-5960-4341
Liceaga, Andrea M. https://orcid.org/0000-0003-0994-1205
Magnani, Marciane
Martin, Rebeca
Mohamad Lal, Mohammad Tamrin
Mora, Diego
Moradi, Mehran https://orcid.org/0000-0002-6004-6874
Morelli, Lorenzo
Mosca, Fabio
Nazzaro, Filomena
Pimentel, Tatiana Colombo https://orcid.org/0000-0003-4600-8932
Ran, Chao
Ranadheera, Chaminda Senaka https://orcid.org/0000-0002-1367-7999
Rescigno, Maria
Salas, Azucena https://orcid.org/0000-0003-4572-2907
Sant’Ana, Anderson S. https://orcid.org/0000-0001-5052-2315
Sivieri, Katia https://orcid.org/0000-0001-8632-1478
Sokol, Harry https://orcid.org/0000-0002-2914-1822
Taverniti, Valentina
Vallejo-Cordoba, Belinda
Zelenka, Jaroslav https://orcid.org/0000-0001-8145-8037
Zhou, Zhigang
- License Information
-
More Information
Article History
First Online: 23 September 2021
Competing interests
: S.A. has research projects sponsored by Sofar, Sacco, Sanofi and Actial Farmaceutica. P.B. has been receiving grants from Ministry of Food Processing Industries for health-promoting exopolysaccharides derived from lactic and probiotic bacteria. C.B. has led research projects sponsored by several industry partners such as Danone-Nutrica, FreislandCampina and Sensus. R.B.C. had the following relevant financial relationships with the following manufacturers: Ch.Hansen (research grant, speaker), iHealth (research grant), Humana (research grant), Kraft-Heinz (research grant, speaker), Mead Johnson Nutrition (research grant, speaker), Nestlè (research grant, speaker), Novalac (research grant), Nutricia (research grant, speaker) and Sofar (research grant) as part of publically funded research projects with the support of the Italian Ministry of Health. E.E. is the founding scientist of DayTwo and BiomX. None of the activities of these entities is related to the topics presented in this commentary. S.G. has led research projects sponsored by several industry partners such as Sofar, 7 Inv, Sacco, Metis Healthcare, Giellepi and Perfetti-Van Melle. S.G. is a consultant for Sofar and Perfetti Van Melle. S.G. receives royalties from the sale of probiotic bacterial strains. P.L. has led research projects with several agro-food (Danone, General Mills, Dupond and Lallemand), food supplements (Pilèje), biotech (Ysopia) and pharmaceutical (Biocodex and Merck) companies and is a co-founder of Exeliom bioscience. M. Magnani has participated in research projects sponsored by industrial partners such as Farmoquímica and Danone Nutricia, the latter not for study of probiotics. D.M. is in the Scientific Advisory Board of Actial Farmaceutica. L.M. is consultant at Bayer, Ferrero, Sanofi and DSM and shareholder in Advanced Analytical Technologies. F.N. participated in a research project funded by Eurolactis (Luxemburg). M.R. has received funding for research collaborations by Kraft-Heinz; Gelesis; and AlfaSigma. She is in the advisory board of MillBo and Gelesis. She is founder and CSO of Postbiotica. K.S. has projects sponsored by industrial partners such as Nestlé and Danone Nutricia, the latter not for the study of probiotics or prebiotics. H.S. received unrestricted study grants from Danone, Biocodex and Enterome; board membership, consultancy, or lecture fees from Carenity, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, M.S.D., Novartis, Roche, Tillots, Enterome, Maat, BiomX, Biose, Novartis and Takeda; and is a co-founder of Exeliom bioscience. V.T. receives royalties from the sale of viable and inactivated probiotic bacterial strains. M. Moradi declares that he has no task or primary function other than the research and education in his university/country. The other authors declare no competing interests.
